Benjamin T. Dake, SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE), sold 20,568 shares at $25.62 ($534K) on 2023-01-06, disclosed to the SEC on 2023-01-09.
Open-market sale of $534k AVTE by SEE REMARKS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.62 | 7,492 | $192K | 35.9% |
| 2 | $25.62 | 7,492 | $192K | 35.9% |
| 3 | $26.95 | 2,792 | $75K | 14.1% |
| 4 | $26.95 | 2,792 | $75K | 14.1% |
| Total | $25.98 avg | 20,568 | $534K | 100% |
| Filing → |
| AVTE | SELL | 2024-03-28 | $619K | — | Filing → |
| AVTE | SELL | 2024-03-27 | $192K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $1.8M | — | Filing → |